Get started
Author

Yuichiro Inagaki

Observed names: Y Inagaki, Y. Inagaki
Institution: Anjo Kosei Hospital
ORCID: 0009-0004-3165-4469
Observed ORCID: 0009-0004-3165-4469
OpenAlex ID: A5063686827
Frequent genetic alterations in immune checkpoint–related genes in intravascular large B-cell lymphoma
2020 · Kazuyuki Shimada, Kenichi Yoshida, et al. · Blood · 91
Divergence and heterogeneity of neoplastic PD‐L1 expression: Two autopsy case reports of intravascular large B‐cell lymphoma
2019 · Ayako Sakakibara, Yuichiro Inagaki, et al. · Pathology International · 20
PDF
Autopsy case report of intravascular large B-cell lymphoma with neoplastic PD-L1 expression
2018 · Ayako Sakakibara, Yuichiro Inagaki, et al. · Journal of the Japan Society of the Reticuloendothelial System · 19
PDF
Disseminated Cutaneous Infection of Mycobacterium colombiense in a Patient with Myelodysplastic Syndrome
2017 · Yuichiro Inagaki, Tatsuya Ito, et al. · Internal Medicine · 15
PDF
Analysis of glutathione S-transferase and cytochrome P450 gene polymorphism in recipients of dose-adjusted busulfan-cyclophosphamide conditioning
2019 · The Nagoya Blood and Marrow Transplantation Group, Seitaro Terakura, et al. · International Journal of Hematology · 11
PAX5 tyrosine phosphorylation by SYK co-operatively functions with its serine phosphorylation to cancel the PAX5-dependent repression of BLIMP1: A mechanism for antigen-triggered plasma cell differentiation
2016 · Yuichiro Inagaki, Fumihiko Hayakawa, et al. · Biochemical and Biophysical Research Communications · 11
A multicenter phase 2 study of empirical low-dose liposomal amphotericin B in patients with refractory febrile neutropenia
2016 · Kotaro Miyao, Masashi Sawa, et al. · International Journal of Hematology · 9
Retention of CD34+ CML stem/progenitor cells during imatinib treatment and rapid decline after treatment with second-generation BCR–ABL inhibitors
2012 · Y Minami, A Abe, et al. · Leukemia · 8
PDF
The Impact of Tirabrutinib Monotherapy for the Treatment of Bing‐Neel Syndrome: A Multicenter Retrospective Study
2025 · Masuho Saburi, Taro Masunari, et al. · American Journal of Hematology · 4
PDF
Long-Term Outcome of Eltrombopag With First-Line Immunosuppressive Therapy for Newly Diagnosed Severe Aplastic Anemia
2024 · Hirofumi Yokota, Kotaro Miyao, et al. · Journal of Hematology · 4
PDF
Development of TCR-T cell therapy targeting mismatched HLA-DPB1 for relapsed leukemia after allogeneic transplantation
2023 · Carolyne Barakat, Yuichiro Inagaki, et al. · International Journal of Hematology · 4
Clinical Benefit of Low-Dose Antithymocyte Globulin-Thymoglobulin as Graft-versus-Host Disease Prophylaxis in Patients Receiving Allogeneic Peripheral Blood Stem Cell Transplantation from HLA-Identical Donors
2023 · Yuki Takeuchi, Kotaro Miyao, et al. · Transplantation and Cellular Therapy · 4
A multicenter phase II study of intrabone single-unit cord blood transplantation without antithymocyte globulin
2021 · Tetsuya Nishida, Takeshi Kobayashi, et al. · Annals of Hematology · 4
Post-transplant TKIs for Ph+ ALL: practices to date and clinical significance
2025 · Satoshi Nishiwaki, Seitaro Terakura, et al. · International Journal of Hematology · 3
Feasibility of trimethoprim/sulfamethoxazole desensitization therapy in hematological diseases
2022 · Shuto Negishi, Kotaro Miyao, et al. · Clinical and Experimental Medicine · 3
Nodal diffuse large B‐cell lymphoma with neoplastic PD‐L1 positivity, but without EBV association: Three cases highlighting an aspect of gray zone lymphoma
2020 · Kei Kohno, Yuka Suzuki, et al. · Pathology International · 3
EBF1–JAK2 inhibits the PAX5 function through physical interaction with PAX5 and kinase activity
2023 · Yukino Kojima, Fumika Kawashima, et al. · International Journal of Hematology · 2
Lymphocyte-depleted classic Hodgkin lymphoma with primary extranodal disease: Two cases that highlight the combination of immunodeficiency and immune escape in the pathogenesis
2021 · Yuta Tsuyuki, Kei Kohno, et al. · Journal of the Japan Society of the Reticuloendothelial System · 2
PDF
Construction of the system of treatment for deep venous thrombosis with malignant tumor in Anjo Kosei Hospital
2015 · Yuichiro Inagaki, Takahiro Suzuki, et al. · Annals of Oncology · 2
PDF
Letermovir improves the outcome of allogenic stem cell transplantation with anti-thymocyte globulin against acute leukemia and myelodysplastic syndromes
2026 · Shuto Negishi, Kotaro Miyao, et al. · Annals of Hematology · 1
PDF
P99-3 The case report of NUT carcinoma administrated VDC-IE therapy
2024 · Y. Inagaki, T. Wakayama, et al. · Annals of Oncology · 1
PDF
Efficacy and Safety of Reduced-Dose Polatuzumab Vedotin, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) in Patients over 80 with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)
2023 · Kotaro Miyao, Tomoyoshi Wakayama, et al. · Blood · 1
Efficacy and safety of modified BLd therapy for Japanese patients with transplant-ineligible multiple myeloma
2022 · Satsuki Murakami, Masaki Ri, et al. · International Journal of Hematology · 1
Correction to: Analysis of glutathione S-transferase and cytochrome P450 gene polymorphism in recipients of dose-adjusted busulfan-cyclophosphamide conditioning
2019 · The Nagoya Blood and Marrow Transplantation Group, Seitaro Terakura, et al. · International Journal of Hematology · 1
PDF
Prospective Analyses of the Utility of Liquid Biopsy in Patients with Fever of Unknown Origin Suspected of Lymphoma
2026 · Akinao Okamoto, Masashi Sanada, et al. · Blood Neoplasia
PDF
Works count: 51
Citation count: 224
H-index: 8
I10-index: 6
Year
Topic
Type